Pharmaceutical supply for NACRE clinical trial by French National Cancer Institute.
The French National Cancer Institute (INCa) is procuring pharmaceutical products for the NACRE clinical trial, a multicenter study evaluating treatments for rare cancers. The contract covers the supply of investigational medicinal products and associated services, including packaging, labeling, and distribution to clinical sites across France. Bidders must have experience in clinical trial supply and comply with Good Manufacturing Practices (GMP). The estimated contract value is between €1 million and €10 million, with a duration of 48 months.